| scholarly article | Q13442814 |
| P2093 | author name string | Ji Won Um | |
| Kwang Chul Chung | |||
| P2860 | cites work | Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism | Q24309753 |
| P433 | issue | 7 | |
| P304 | page(s) | 1543-1554 | |
| P577 | publication date | 2006-11-01 | |
| P1433 | published in | Journal of Neuroscience Research | Q6295654 |
| P1476 | title | Functional modulation of parkin through physical interaction with SUMO-1. | |
| P478 | volume | 84 |
| Q37224705 | Covalent ISG15 conjugation positively regulates the ubiquitin E3 ligase activity of parkin |
| Q45733826 | Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart |
| Q39823990 | DNA damage induces nuclear translocation of parkin |
| Q58605544 | Developing Practical Therapeutic Strategies that Target Protein SUMOylation |
| Q26799306 | Direct and/or Indirect Roles for SUMO in Modulating Alpha-Synuclein Toxicity |
| Q38876446 | Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity |
| Q36995104 | Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction |
| Q28533874 | Host response to respiratory bacterial pathogens as identified by integrated analysis of human gene expression data |
| Q43123357 | Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin. |
| Q27865251 | Mechanisms, regulation and consequences of protein SUMOylation |
| Q39665306 | Membrane lipid modification by docosahexaenoic acid (DHA) promotes the formation of α-synuclein inclusion bodies immunopositive for SUMO-1 in oligodendroglial cells after oxidative stress |
| Q40161850 | Modulation of Abeta generation by small ubiquitin-like modifiers does not require conjugation to target proteins |
| Q38115818 | Molecular targets underlying SUMO-mediated neuroprotection in brain ischemia |
| Q48695224 | Neddylation positively regulates the ubiquitin E3 ligase activity of parkin |
| Q34295237 | Neuronal SUMOylation: mechanisms, physiology, and roles in neuronal dysfunction |
| Q37883939 | Parkin, A Top Level Manager in the Cell's Sanitation Department |
| Q64866434 | Parkinson's disease-associated protein Parkin: an unusual player in cancer |
| Q39145536 | Post translational modification of Parkin |
| Q37553976 | Protein SUMOylation in neuropathological conditions. |
| Q37789075 | Protein modifications involved in neurotransmitter and gasotransmitter signaling |
| Q26828565 | RBR E3 ubiquitin ligases: new structures, new insights, new questions |
| Q38182404 | RBR E3-ligases at work |
| Q38004927 | Regulation of Parkin E3 ubiquitin ligase activity. |
| Q47216699 | Regulation of mitophagy by the ubiquitin pathway in neurodegenerative diseases |
| Q92752474 | SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function |
| Q37297379 | SUMO and Alzheimer's disease |
| Q38131751 | SUMO and Parkinson's disease |
| Q39228154 | SUMO-1 is associated with a subset of lysosomes in glial protein aggregate diseases |
| Q58134146 | SUMO-1 promotes degradation of the polyglutamine disease protein ataxin-3 |
| Q38757045 | SUMO-regulated mitochondrial function in Parkinson's disease |
| Q38139897 | SUMO: a (oxidative) stressed protein. |
| Q58717509 | SUMOs Mediate the Nuclear Transfer of p38 and p-p38 during Infection |
| Q97884803 | SUMOylation and calcium signalling: potential roles in the brain and beyond |
| Q58705758 | SUMOylation of Alpha-Synuclein Influences on Alpha-Synuclein Aggregation Induced by Methamphetamine |
| Q41299145 | SUMOylation of the Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel 2 Increases Surface Expression and the Maximal Conductance of the Hyperpolarization-Activated Current |
| Q34396844 | Selective impairment of a subset of Ran-GTP-binding domains of ran-binding protein 2 (Ranbp2) suffices to recapitulate the degeneration of the retinal pigment epithelium (RPE) triggered by Ranbp2 ablation. |
| Q38118140 | Starting and stopping SUMOylation. What regulates the regulator? |
| Q92577436 | Stress-induced phospho-ubiquitin formation causes parkin degradation |
| Q26747536 | Sumoylation in Synaptic Function and Dysfunction |
| Q38046126 | Sumoylation in neurodegenerative diseases |
| Q47799714 | Sumoylation: Implications for Neurodegenerative Diseases |
| Q37728628 | Targets and consequences of protein SUMOylation in neurons. |
| Q61448146 | The Transcription Factor Function of Parkin: Breaking the Dogma |
| Q28117293 | The parkin-like human homolog of Drosophila ariadne-1 (HHARI) can induce aggresome formation in mammalian cells and is immunologically detectable in Lewy bodies |
| Q36762636 | The ring between ring fingers (RBR) protein family |
| Q37320375 | The role of PTEN-induced kinase 1 in mitochondrial dysfunction and dynamics |
| Q39377582 | Twenty years since the discovery of the parkin gene |
| Q36307179 | Ubiquitin proteolytic system: focus on SUMO. |
| Q38874015 | Ubiquitin-dependent and independent roles of SUMO in proteostasis |
Search more.